|
US2012046237A1
|
|
Compositions for protection against superficial vasodilator flush syndrome, and methods of use
|
|
US2011183019A1
|
|
Methods of screening for and treating autism spectrum disorders and compositions for same
|
|
US2011027397A1
|
|
Methods of treating autism spectrum disorders and compositions for same
|
|
US2008153761A1
|
|
Compositions for protection against superficial vasodilator flush syndrome, and methods of use
|
|
US2007077317A1
|
|
Olive kernel composition containing absorption promoters, antioxidants, and anti-inflammatory agents
|
|
US2005220909A1
|
|
Composition for protection against superficial vasodilator flush syndrome
|
|
US2005220907A1
|
|
Implanted medical devices with anti-inflammatory coatings
|
|
US2005220912A1
|
|
Anti-inflammatory composition for treating pelvic endometriosis
|
|
US2005220908A1
|
|
Anti-inflammatory compositions for multiple sclerosis
|
|
US7115278B2
|
|
Proteoglycan compositions for the treatment of cardiovascular inflammatory diseases
|
|
EP1365777A2
|
|
Compositions comprising proteoglycan and their use for the treatment of inflammatory conditions
|
|
US6689748B1
|
|
Method of treating mast cell activation-induced diseases with a proteoglycan
|
